Recent Company News

• 03:48 AM ET Jun 09, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (50 total)

• 12:08 AM ET Jun 09, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (181 total)

• 04:57 AM ET Jun 08, 2026
  

  Innovent Biologics presents multiple clinical, preclinical results at 2026 ADA (HK$73.25, 0.00)

• 02:09 AM ET Jun 05, 2026
  

  StreetAccount Sector Summary - China Healthcare May Recap

• 04:43 AM ET Jun 04, 2026
  

  La NMPA accepte la demande d’AMM prioritaire d’Innovent Biologics pour l’IBI343 dans le cancer gastrique avancé (HK$76.40, 0.00)

• 04:43 AM ET Jun 04, 2026
  

  NMPA accepts Innovent Biologics' IBI343 NDA with priority review for advanced gastric cancer (HK$76.40, 0.00)

• 08:06 PM ET May 31, 2026
  

  Innovent Biologics presents preliminary PoC data of IBI363 at ASCO (HK$83.35, 0.00)

• 07:39 PM ET May 31, 2026
  

  Ascentage Pharma presents data on alrizomadlin and olverembatinib at ASCO 2026 (HK$39.24, 0.00)

• 05:03 PM ET May 31, 2026
  

  Eli Lilly reports results from Phase 3 LIBRETTO-432 study presented at ASCO and published in NEJM ($1105.00, 0.00)

• 10:40 PM ET May 29, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap